Navigation Links
GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
Date:12/5/2008

is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. Additional clinical trials are in progress in rectal cancer, head and neck cancer, and melanoma. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and influenza. Additional information about GenVec is available at www.genvec.com and in the company's various filings with the Securities and Exchange Commission.

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding future revenues and operating expenses, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. GenVec cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failure by GenVec to secure and maintain relationships with collaborators; risks relating to the early stage of GenVec's product candidates under development; uncertainties relating to clinical trials; risks relating to the commercialization, if any, of GenVec's proposed product candidates; dependence on the efforts of third parties; dependence on intellectual property; and risks that we may lack the financial resources and access to capital to fund our operations. Further information on the factors and risks that could affect GenVec's business, financial conditions and results of operations, are contained in GenVec's filin
'/>"/>

SOURCE GenVec, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
2. ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
3. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
4. Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
5. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
6. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
7. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
8. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
9. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
10. GeneThera Announces it is Set to Begin Commercial Testing for Johnes Disease as Soon as January, 2009.
11. Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... operator of specialty cancer hospitals and the largest ... China, today announced its unaudited consolidated financial results ... [1] . Third Quarter 2014 Highlights ... net revenues generated from the network business and ...
(Date:11/18/2014)... , Nov. 18, 2014  Zimmer Holdings, Inc. ... has agreed with the European Commission (the "EC") to ... proposed acquisition of Biomet by a limited number of ... additional information. Deadline extensions are not ... closely with the regulatory authorities to facilitate their review ...
(Date:11/18/2014)... , Nov. 18, 2014  A new global survey ... that a large majority of the general public feel ... a devastating disease that is responsible for 1.59 million ... combined 1,2,4 . The "Any One Any Lung" survey ... the widespread impact of lung cancer, but also a ...
Breaking Medicine Technology:Concord Medical Reports Third Quarter 2014 Financial Results 2Concord Medical Reports Third Quarter 2014 Financial Results 3Concord Medical Reports Third Quarter 2014 Financial Results 4Concord Medical Reports Third Quarter 2014 Financial Results 5Concord Medical Reports Third Quarter 2014 Financial Results 6Concord Medical Reports Third Quarter 2014 Financial Results 7Concord Medical Reports Third Quarter 2014 Financial Results 8Concord Medical Reports Third Quarter 2014 Financial Results 9Concord Medical Reports Third Quarter 2014 Financial Results 10Concord Medical Reports Third Quarter 2014 Financial Results 11Concord Medical Reports Third Quarter 2014 Financial Results 12Concord Medical Reports Third Quarter 2014 Financial Results 13Concord Medical Reports Third Quarter 2014 Financial Results 14Concord Medical Reports Third Quarter 2014 Financial Results 15Concord Medical Reports Third Quarter 2014 Financial Results 16Concord Medical Reports Third Quarter 2014 Financial Results 17Concord Medical Reports Third Quarter 2014 Financial Results 18Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 2Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 3Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 4Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 5Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 6
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. ... verge of burning out are more likely to develop heart ... vital exhaustion -- a toxic combination of fatigue, irritability and ... heart disease, researchers report. "In our increasingly busy lives, ... when that stress is left unchecked for a period of ...
(Date:11/18/2014)... By Dennis Thompson HealthDay ... doctor from Sierra Leone who became infected with Ebola in his ... Dr. Martin Salia had arrived Saturday at Nebraska Medical Center ... at a hospital in Sierra Leone,s capital city of Freetown. ... that have been ravaged by the Ebola outbreak that began last ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. 17, 2014 (HealthDay ... them track how many calories they consume each day, but ... one after their doctor recommended it did not lose any ... using such apps as weight-loss tools. Some participants were barely ... varied, the researchers noted, and they added that they believe ...
(Date:11/17/2014)... 2014 Vernon Brewer, Founder and President of ... two weeks and saw firsthand the devastating holocaust that ISIS ... Iraq and Syria. , “‘Holocaust’ is not a term I ... or driven thousands of Christians and members of other faiths ... is desperate. As ISIS expands, they continue to kill ...
(Date:11/17/2014)... November 17, 2014 Home Care Assistance ... provider of non-medical, in-home senior care, is advising seniors ... , Aging typically weakens the immune system and makes ... the flu. This is a greater concern at this ... more prevalent; during last year’s influenza season (November to ...
Breaking Medicine News(10 mins):Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 2Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 3
... smell better is due to the boding of the hormone, ... age are far better in sensing the fragrance than men ... said: "Some studies have shown that during ovulation, there's a ... nose is the same in women as men. Theories have ...
... common problem for heavy drinkers and the scientist have found ... the potentialities of a night out. ,Researchers at the ... in Minnesota say the effect of alcohol on blood vessels ... healthy young adults, that blood vessels do not strengthen so ...
... weekend alcohol flings and the stress of going back to ... heart attack. A 7 year study carried out in Australia ... attacks on a Monday than any other day. ,Experts ... exorbitant drinking and coronary heart disease.//They suggested the stresses of ...
... putting its best foot forward in completing its ... company promote Zyban, its anti-smoking drug. Glaxo is ... of its policy, along with providing teams to ... of the corporate, which have negotiated for this ...
... prevented in prostate cancer patients who are undergoing ... The researchers at the New York Cornell Medical ... be considered as a monotherapy in men who ... the researchers evaluated 54 patients with clinically localised ...
... Brain surgery, endoscopies and other complicated medical procedures could ... using computers. Scientists from the University of California, Los ... interact with their environment and are attempting to design ... surgeons routinely use technology that is capable of producing ...
Cached Medicine News:
... Diagnostic, Non-Donor Screen. Vironostika HIV assays ... for additional testing and confirmation. Vironostika ... assay for the detection of antibody to ... spots. Oral Fluid Vironostika HIV-1 Microelisa ...
... OraSure HIV-1 Oral Specimen Collection Device is a ... HIV-1 antibodies. Testing with the OraSure HIV-1 Oral ... and has been shown to be more than ... treated cotton fiber pad attached to a nylon ...
... Angle CHS System takes the time proven ... , ,The VHS® Supracondylar Cable Plate is ... distal femur fractures including periprosthetic fractures. The ... variable angle of the barrel and the ...
Coronet Vacuum Trephine - All metal, ergonomic design and ultra sharp blade with cross hairs....
Medicine Products: